advertisement
E-mail Page
Print Format
Google - Traducir esta página a español.
Google - Traduza esta página ao português.
 

  Back to Ask the Diabetes Team Ask the Diabetes Team
Question:

From Lancaster, Missouri, USA:

I am a 51 male nonsmoker with Type 2 diabetes, and I have two questions. What can be taken to stop lymphocytes from killing cells that produce insulin? What causes the dawn phenomenon?

Answer:

Stopping the progression of Type 1 diabetes will be worthy of a Nobel Prize in my opinion. That said, we really don't have a good way as of now. We tried some anti-rejection drugs used in transplants. They work but you can't take them for life. The DPT-1 study is evaluating ways to prevent diabetes. Some have shown a bit of success using insulin as an oral agent after diagnosis, but it's not a great success.

The dawn phenomenon is defined as rising glucose in the early morning. Why?... to wake you up and give you energy. With diabetes, there isn't enough insulin in the early morning on occasions and the glucose rises. Also other hormones such as growth hormone, cortisol, and others cause the glucose to rise. The trick is to take enough insulin to keep the glucose okay in the early morning but not too low in the middle of the night.

LD

DTQ-20000328121825
Original posting 29 Jun 2000
Posted to Research: Cure

  
advertisement


 
Not Helpful  1 2 3 4 5  Very Helpful                  E-mail Article E-mail Page     Printer Friendly format Print Format    
  Home Return to Top

Last Updated: Tuesday April 06, 2010 15:09:09
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

US Flag This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, Privacy Policy, and Safe Harbor Policy.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.